Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0129
-0.0037 (-22.29%)
At close: Nov 5, 2026
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $5.9 million as of November 5, 2026. It is the 44,040th most valuable company in the world and the 5,842nd biggest in the United States. Its market cap has decreased by 86.57% in one year.
Market Cap
5.90M
Enterprise Value
18.49M
Revenue
250.00K
Global Rank
Country Rank
#5,842 United States
PE Ratio
0.02
ChartMarket Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has decreased from 9.14M to 5.90M, a decrease of -35.45%. That is a compound annual growth rate of -5.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 5.90M | -84.10% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anebulo Pharmaceuticals | 10.60M |
| NDT Pharmaceuticals | 8.60M |
| Zeo ScientifiX | 7.60M |
| Adaptimmune Therapeutics | 6.63M |
| EOM Pharmaceuticals Holdings | 6.59M |
| VitaSpring Biomedical | 6.58M |
| TRON Group | 6.53M |
| OSR Health | 5.97M |